Stratified-care school program for teens with suicidal thoughts
Official title: Acceptability and Feasibility of a Stratified-Care School-Based Intervention for Adolescent Suicidal Ideation in Chile: A Study Protocol
Run by Universidad de los Andes, Chile · NCT07063914 · Data updated 2026-11-12
This program will try a stepped CBT approach using Reframe-IT+ for teens with mild/moderate depression and CARIBOU for those with severe depression to reduce suicidal thoughts in high-school students in vulnerable Santiago schools.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 18 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Universidad de los Andes, Chile Academic / other |
| Locations | 1 site (Santiago, Las Condes) |
| Status | Recruiting |
| Started | June 25, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 1, 2025 |
| Trial ID | NCT07063914 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are students enrolled in grades I–III Medio at participating Santiago schools who report suicidal ideation in the past month (C-SSRS ≥ 3) and meet the PHQ-9 cutoffs for either the Reframe-IT+ (PHQ-9 < 20) or CARIBOU (PHQ-9 ≥ 20) program.
✕Probably not a fit
Students not enrolled in the participating schools or grades, those without recent suicidal ideation, or those already engaged in a structured suicide-prevention program may not receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm, quasi-experimental project delivering a culturally adapted stratified-care model in six secondary schools in Santiago, Chile, with pre-post measurements and follow-ups at 3, 6, 9, and 12 months. Students with recent suicidal ideation are screened with the C-SSRS and PHQ-9 and are routed to Reframe-IT+ if their PHQ-9 is below 20 or to CARIBOU if their PHQ-9 is 20 or higher. Both interventions are individually delivered, CBT-based programs adapted for the local context and aimed at reducing depressive symptoms and suicidal ideation. The study focuses on schools with high socioeconomic vulnerability and collects outcome data over one year to measure change.
Why it matters
Potential benefit: If successful, the program could reduce suicidal thoughts and depressive symptoms by providing timely, severity-matched CBT interventions delivered in schools.
How similar studies have gone: Previous school-based CBT programs including earlier Reframe-IT and CARIBOU work have shown promising reductions in depressive symptoms and suicidal ideation, though using a stratified-care matching by severity in this setting is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion Criteria for Educational Institutions * Located in Santiago, Chile. * Secondary education level (grades I-IV Medio). * Coeducational schools. * At least two classes per grade level in secondary education. * A minimum of 30 students per class. * Socioeconomic vulnerability level of ≥ 50%, as measured by the School Vulnerability Index (Índice de Vulnerabilidad Escolar - IVE-SINAE), which includes factors such as parental education and total household income. Inclusion Criteria for Students * Enrolled in grades I, II, or III Medio. * Suicidal ideation within the past month, defined as a score ≥ 3 on the Columbia-Suicide Severity Rating Scale (C-SSRS). * For the Reframe-IT+ program: mild or moderate depressive symptoms, defined as a PHQ-9 score \< 20. * For the CARIBOU program: severe depressive symptoms, defined as a PHQ-9 score ≥ 20. Exclusion Criteria: * Exclusion Criteria for Students * Participation in a structured suicide prevention program (Reframe-IT+) during 2024. * Severe psychotic symptoms, such as perceptual disturbances or delusional ideas, assessed during the eligibility interview. * Suicide attempt(s) in the past three months, assessed during the eligibility interview.
Where it's running
-
Universidad de los Andes
Santiago, Las Condes, Chile Recruiting
Study contacts
- Study coordinator: Jorge E Gaete, MD, PhD
- Email: jgaete@uandes.cl
- Phone: +56940245650
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department
This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
-
Student Precarity and Psychiatry: How Financial Struggles Relate to Depression and Loneliness
This observational study looks at whether financial hardship and social isolation are linked to depression, suicidal thoughts, and loneliness among French university students.
-
Ketamine with DBT for suicidality in adults with treatment-resistant depression or bipolar disorder and BPD
This study tests whether four ketamine infusions plus Dialectical Behavioural Therapy can more quickly reduce suicidal thoughts in adults with Borderline Personality Disorder and treatment-resistant depression or bipolar disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.